Gene · 5355
Papers1,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acquired temozolomide resistance in MGMTlow gliomas is associated with regulation of homologous recombination repair by ROCK2. | Cell Death Dis | 2022 | 35145081 | PubTator, text mining | PubMed |
| A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection. | PLoS Pathog | 2022 | 35143592 | PubTator, text mining | PubMed |
| Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth. | Oncogene | 2022 | 35124697 | PubTator, text mining | PubMed |
| The tyrosine kinase inhibitor LPM4870108 impairs learning and memory and induces transcriptomic and gene‑specific DNA methylation changes in rats. | Arch Toxicol | 2022 | 35098321 | PubTator, text mining | PubMed |
| The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells. | Cell Mol Gastroenterol Hepatol | 2022 | 35093591 | PubTator, text mining | PubMed |
| Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells. | J Exp Clin Cancer Res | 2022 | 35073964 | PubTator, text mining | PubMed |
| The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC. | Cancer Immunol Immunother | 2022 | 35066605 | PubTator, text mining | PubMed |
| A Defective Viral Particle Approach to COVID-19. | Cells | 2022 | 35053418 | PubTator, text mining | PubMed |
| Structural Characterization of the Human Cytosolic Malate Dehydrogenase I. | ACS Omega | 2022 | 35036692 | PubTator, text mining | PubMed |
| Long non‑coding RNA LINC00238 suppresses the malignant phenotype of liver cancer by sponging miR‑522. | Mol Med Rep | 2022 | 35014686 | PubTator, text mining | PubMed |
| Autophagy facilitates age-related cell apoptosis-a new insight from senile cataract. | Cell Death Dis | 2022 | 35013122 | PubTator, text mining | PubMed |
| ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection. | iScience | 2022 | 35005526 | PubTator, text mining | PubMed |
| PRR11 induces filopodia formation and promotes cell motility via recruiting ARP2/3 complex in non-small cell lung cancer cells. | Genes Dis | 2022 | 35005120 | PubTator, text mining | PubMed |
| PEA-15 engages in allosteric interactions using a common scaffold in a phosphorylation-dependent manner. | Sci Rep | 2022 | 34997083 | PubTator, text mining | PubMed |
| AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma. | J Exp Clin Cancer Res | 2022 | 34991674 | PubTator, text mining | PubMed |
| A novel imatinib-upregulated long noncoding RNA plays a critical role in inhibition of tumor growth induced by Abl oncogenes. | Mol Cancer | 2022 | 34980123 | PubTator, text mining | PubMed |
| Analysis of a crucial interaction between the coronavirus nucleocapsid protein and the major membrane-bound subunit of the viral replicase-transcriptase complex. | Virology | 2022 | 34933176 | PubTator, text mining | PubMed |
| IPSC-Derived Human Neurons with GCaMP6s Expression Allow In Vitro Study of Neurophysiological Responses to Neurochemicals. | Neurochem Res | 2022 | 34855047 | PubTator, text mining | PubMed |
| PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ. | Cell Chem Biol | 2022 | 34813762 | PubTator, text mining | PubMed |
| Viral deubiquitinases and innate antiviral immune response in livestock and poultry. | J Vet Med Sci | 2022 | 34803084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5355/papers?page=16